Prognostic value of potential biomarkers in prostate cancer via bioinformatic analysis

Journal Title: TMR Integrative Medicine - Year 2021, Vol 5, Issue 15

Abstract

Background: The Genotype-Tissue Expression was used to expanded normal tissue of the Cancer Genome Atlas database. This study aimed to investigate genes associated with the pathogenesis and prognosis of prostate cancer. Methods: We conducted prognostic related genes for prostate cancer by using transcriptome data from the Genotype-Tissue Expression Project and the Cancer Genome Atlas data sources, which were analyzed using an integrated bioinformatics strategy. Clinically significant modules were distinguished, and GO and KEGG analysis were used to Database for Annotation, Visualization and Integrated Discovery. Further annotation was performed through Gene set enrichment analysis. Logistic regression was carried out to analyze the associations between clinicopathologic characteristics and the hub genes. Logistic regression model and survival analysis were performed. Results: By using data available from the Cancer Genome Atlas and the Genotype-Tissue Expression databases, we here show that 53 differential expression genes were identified. Through GO and KEGG analysis a prognostic related gene signature consisted of GOLM1, EIF4A1, ABCC4, RPL7P16, NPIPB12 and PCA3 was constructed with a good performance in predicting overall survivals. The majority of the six hub genes were associated with clinical characteristics of prostate cancer. Conclusion: These genes might be considered as new targets for further investigating the diagnostic and prognostic biomarkers to facilitate the molecular targeting therapy since they showed differently expressed in prostate cancer and correlate with overall survival prognosis.

Authors and Affiliations

Shan-Qi Guo, Hao Deng, Ying-Jie Jia, Xiao-Jiang Li, Xing-Kang Jiang

Keywords

Related Articles

Meta-analysis of efficacy and safety of Qianliexin capsule combined with western medicine in benign prostatic hyperplasia treatmen

Objective: To systematically evaluate the efficacy and safety of Qianliexin capsule combined with western medicine in benign prostatic hyperplasia treatment. Methods: Randomized controlled trials of Qianliexin capsule co...

Effectiveness and safety of acupuncture on cancer pain: a meta-analysis

Objective: The aim of the study was to evaluate the efficacy of acupuncture combined with opiates in the treatment of cancer pain through the meta-analysis system. Methods: China national knowledge infrastructure and VIP...

TMR Integrative Medicine

Eczema (Nār Fārsī) is characterized by itching, lichenification, scaling, oedema and erythema. Corticosteroids are the mainstay of current management of this disease in modern medicine, which is also limited due to its s...

Possible effect of fenugreek on cystic fibrosis

Cystic fibrosis (CF) is indeed an autosomal recessive genetic disorder caused by CFTR gene mutations that lead to chloride channel abnormalities in sweat producing cells and mucus. The gastrointestinal tract and the resp...

Application of diffusion kurtosis imaging technology in evaluating early mild traumatic brain injury

Objective To explore the value of magnetic resonance diffusion kurtosis imaging in diagnosing early tiny changes of brain tissue after mild traumatic brain injury. Methods A total of 22 patients with mild traumatic brain...

Download PDF file
  • EP ID EP697534
  • DOI 10.12032/TMRIM202105015
  • Views 72
  • Downloads 0

How To Cite

Shan-Qi Guo, Hao Deng, Ying-Jie Jia, Xiao-Jiang Li, Xing-Kang Jiang (2021). Prognostic value of potential biomarkers in prostate cancer via bioinformatic analysis. TMR Integrative Medicine, 5(15), -. https://europub.co.uk/articles/-A-697534